drugset / Trial / NCT03716375

Efficacy of Fibrinolytic Agents in Complicated Pleural Effusion

NCT03716375

Unknown 80 enrolled Beijing Children's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Intrapleural administration of fibrinolytic therapy, urokinase in parapneumonic effusion and empyema has been shown to decrease the need for surgical intervention and length of hospital stay. Pleural adhesions are easily formed in the early stages of empyema and the thickening of the pleural causes subsequent treatment difficulties. The goal of this study was to observe and compare the efficacy of treatment in empyema patients with urokinase and chest drainage or with chest drainage or with chest tube drainage alone so as to provide evidence for guiding clinical treatment.

Timeline

Start
2018-11
Primary completion
2019-04-30
Completion
2020-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Urokinase Protein / enzyme biologic 10000 iu Other
Subject Urokinase Protein / enzyme biologic 40000 iu Other

Indications